The treatment involves editing the DNA in white blood cells to transform them into a cancer-fighting "living drug".
🧪🩸🧬 #medsky
www.bbc.co.uk/news/article...
The treatment involves editing the DNA in white blood cells to transform them into a cancer-fighting "living drug".
🧪🩸🧬 #medsky
www.bbc.co.uk/news/article...
Registration by 23 Jan 2026
Abstract submission by 15 Dec 2025
https://meetings.embo.org/event/26-limb-dev
#EMBOLimbDev #GeneSky #EMBOevents 🧪
Registration by 23 Jan 2026
Abstract submission by 15 Dec 2025
https://meetings.embo.org/event/26-limb-dev
#EMBOLimbDev #GeneSky #EMBOevents 🧪
🧵1/4 Excited to share our work on AI-guided design of minimal RNA-guided nucleases. Amazing work by @petrskopintsev.bsky.social @isabelesain.bsky.social @evandeturk.bsky.social et al!
Multi-lab collaboration @banfieldlab.bsky.social @jhdcate.bsky.social @jacobsenucla.bsky.social🧬
🔗👇
🧵1/4 Excited to share our work on AI-guided design of minimal RNA-guided nucleases. Amazing work by @petrskopintsev.bsky.social @isabelesain.bsky.social @evandeturk.bsky.social et al!
Multi-lab collaboration @banfieldlab.bsky.social @jhdcate.bsky.social @jacobsenucla.bsky.social🧬
🔗👇
Focus: Infectious diseases, host-microbe interactions, vaccines
Special interest: AI methodologies
📅 Deadline: Feb 9, 2026
👥 2-12 years post-PhD
Apply now 📝 research.pasteur.fr/en/call/crea...
#JobOpportunity #Research
Focus: Infectious diseases, host-microbe interactions, vaccines
Special interest: AI methodologies
📅 Deadline: Feb 9, 2026
👥 2-12 years post-PhD
Apply now 📝 research.pasteur.fr/en/call/crea...
#JobOpportunity #Research
In October, researchers from @rdm.ox.ac.uk engaged with the public, asking "How much do you know about what’s going on in your gut?". Children created their own salmonella using Play-Doh and adults played Micropoly.
In October, researchers from @rdm.ox.ac.uk engaged with the public, asking "How much do you know about what’s going on in your gut?". Children created their own salmonella using Play-Doh and adults played Micropoly.
Learn about his return to the @hubrechtinstitute.bsky.social and his experience running the Institute of Human Biology at Roche: https://bit.ly/48sIRIV
Learn about his return to the @hubrechtinstitute.bsky.social and his experience running the Institute of Human Biology at Roche: https://bit.ly/48sIRIV
Can you please add me to your 3D chromatin starter pack. Thanks for starting it :)
Can you please add me to your 3D chromatin starter pack. Thanks for starting it :)
Molecular basis for de novo thymus regeneration in a vertebrate, the axolotl | Science Immunology www.science.org/doi/10.1126/...
Molecular basis for de novo thymus regeneration in a vertebrate, the axolotl | Science Immunology www.science.org/doi/10.1126/...
The piece is available open access in Nature Communications:
www.nature.com/articles/s41...
The piece is available open access in Nature Communications:
www.nature.com/articles/s41...
www.bbc.com/news/article...
www.bbc.com/news/article...
Mentoring
Profile raising
Leadership training
Network building
Spread the word...
www.biologists.com/grants/devel...
Mentoring
Profile raising
Leadership training
Network building
Spread the word...
www.biologists.com/grants/devel...
☀️ Join our vibrant and international research community in sunny Lisbon!
🔗 fchampalimaud.org/champalimaud...
☀️ Join our vibrant and international research community in sunny Lisbon!
🔗 fchampalimaud.org/champalimaud...
Today at 4.00 pm in the Blakemore Lecture Theatre, Sherrington Building (University cards required to gain access)
Today at 4.00 pm in the Blakemore Lecture Theatre, Sherrington Building (University cards required to gain access)
www.biorxiv.org/content/10.6...
www.biorxiv.org/content/10.6...
SMARCA2/4-Dependent Chromatin Remodelling Establishes Gene Regulatory Programs in Early Human Embryos and Blastoids.
www.biorxiv.org/content/10.64898/2025.12.01.691499v1
SMARCA2/4-Dependent Chromatin Remodelling Establishes Gene Regulatory Programs in Early Human Embryos and Blastoids.
www.biorxiv.org/content/10.64898/2025.12.01.691499v1
Come and join us to develop novel human organoid systems as part of the MRC/BHF CRE in advanced cardiac therapies.